The Rho-associated kinase inhibitor fasudil can replace Y-27632 for use in human pluripotent stem cell research. So S, Lee Y, Choi J, Kang S, et al. PLoS One 2020;15:e0233057.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

So S, Lee Y, Choi J, Kang S, et al. The Rho-associated kinase inhibitor fasudil can replace Y-27632 for use in human pluripotent stem cell research. PLoS One 2020;15:e0233057.
PMID: 32396545